alexa Dr. Shamim Ahmad | Augusta University
ISSN: 2168-9652

Biochemistry & Physiology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Dr. Shamim Ahmad

Dr. Shamim Ahmad Shamim Ahmad
Cancer Center
Augusta University
Augusta, GA
USA
Biography

Dr. Ahmad has extensive research experience in the field of Immunology, Biochemistry and cell signaling. The broad aim of his research is examination of cellular and molecular mechanisms differentially regulating the signaling of T cell subset signaling, function and survival. The aim of in depth examination of these signaling pathways is the development of strategies to selectively manipulate specific subsets to enhance the efficacy of immune therapies. Phosphoinositide 3-kinase (PI3K)-Akt signaling is important for the differentiation, proliferation, and survival of a variety of cells, including immune cells. Dr. Shamim Ahmad evaluated the anti-tumor efficacy of combinational immunotherapy based on model vaccine and PI3K isoform specific inhibitor. He demonstrates that this treatment leads to a profound inhibition of tumor growth. He showed that the potent therapeutic efficacy of treatment is mediated by i) enhancing number of the effector T cells infiltrating into the tumor that is facilitated and ii) the decrease Tregs. Thus, he provides a promising and translatable strategy that can enhance the overall efficacy of cancer immunotherapy.

Research Interest

His research is focused on development of combinational cancer immunotherapies, immune corrective strategies and investigation of cellular and molecular mechanisms involved in tumor-mediated immune suppression, and development of strategies to overcome that suppression.

Certificate
Certificate
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords